Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: Amblyopia
In brief
This is a prospective, randomized, parallel group sham-controlled blinded clinical trial to assess the feasibility and efficacy of transcorneal electrical stimulation (TES) in the improvement of visual function outcomes in adults with amblyopia. The trial will assess the treatment effect of TES to Sham TES in the amblyopic eye of affected patients.
Key facts
- Study ID
- NCT02495935
- Run by
- Wills Eye
- People needed
- 40
- Starts
- 2015-07-01
- Expected to finish
- 2020-08-01
- Last updated by the study team
- 2020-03-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Diagnosis of amblyopia made by the principal investigators.
- Best corrected visual acuity in the amblyopic eye equal to or worse than 20/70
- Willing and able to give informed consent and to participate for the full duration of the study.
- Strabismus less than 10 prism diopters.
You may not qualify if…
- Any other significant ophthalmologic disorder or condition with relevant effect upon visual function as evaluated by principal investigator. (eg. Retinal degeneration, proliferative diabetic retinopathy, age related macular degeneration, optic nerve abnormality)
- Women who are pregnant or women with childbearing potential who are unwilling to use medically acceptable means of birth control for study duration.
- Presence of a pacemaker, any metal artifacts in head and trunk, any history of epileptic seizure or severe psychiatric disease (schizophrenia, etc.)
- Inability to detect phosphenes above 0.5mA at time of threshold detection.
Where it is running
- WillsEye Hospital — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.